Author:
Holmes Jacinta A.,Chung Raymond T.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Woolley, A. E. et al. Heart and lung transplants from HCV-infected donors to uninfected recipients. N. Engl. J. Med. 380, 1606–1617 (2019).
2. Bethea, E. D. et al. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study. Lancet Gastroenterol. Hepatol. 4, 771–780 (2019).
3. Bourliere, M. et al. sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection. N. Engl. J. Med. 376, 2134–2146 (2017).
4. Belperio, P. S., Shahoumian, T. A., Loomis, T. P. & Backus, L. I. Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients. J. Viral. Hepat. 26, 980–990 (2019).
5. Sarrazin, C. et al. No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients. J. Hepatol. 69, 1221–1230 (2018).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献